January 2026 – Milan, Italy & Munich, Germany

DBA Italia is pleased to announce a new distribution partnership with Xpedite Diagnostics, becoming the official distributor of Xpedite products in Italy starting January 2026.

Through this collaboration, Italian research and diagnostic laboratories will gain easier access to Xpedite Diagnostics’ innovative reverse purification technology for nucleic acid extraction. Local distribution by DBA Italia will ensure faster delivery, reliable product availability, and dedicated in-country sales and technical support.

“We are pleased to partner with Xpedite Diagnostics and bring their innovative nucleic acid extraction solutions to the Italian market,” said Marco D’Erasmo, CEO of DBA Italia, “Xpedite’s technologies offer a strong alternative to traditional extraction methods, particularly for laboratories seeking faster and more flexible workflows. Through this collaboration, we can support Italian customers with both locally available products and dedicated technical expertise.”

The partnership strengthens Xpedite Diagnostics’ presence in Southern Europe and reflects the company’s commitment to supporting laboratories with technologies that reduce complexity, accelerate molecular workflows, and enable reliable results across research, surveillance, and diagnostic applications.

From January 2026, Xpedite Diagnostics products will be available directly through DBA Italia. For more information or to discuss your laboratory needs, please contact our team.